Streetbeat News

Regulatory

ABT

Abbott's FreeStyle Libre 2 continuous glucose monitoring system has received national reimbursement in France for all people with diabetes who use insulin. France is the first European country to grant national reimbursement for people who use basal insulin, following similar expansions in Japan and the U.S. (Medicare).

Portfolio Pulse from Happy Mohamed

June 22, 2023 | 1:01 pm

GSK

PFE

The CDC's Advisory Committee on Immunization Practices has voted in favor of recommending Pfizer and GSK's RSV vaccines for older adults aged 60 and above. The FDA has approved both vaccines, but the panel advises patients to consult their doctors before taking the shots. Both companies expect to supply the vaccines ahead of the RSV season later this year.

Portfolio Pulse from Vandana Singh

June 22, 2023 | 12:56 pm

EOLS

Evolus has completed its Phase 2 study evaluating the extra-strength dose of Jeuveau, with the full dataset presentation planned for a medical meeting in Q4 2023.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 12:50 pm

JPM

JPMorgan Chase has appointed Teresa Heitsenrether to lead a new AI-driven data and analytics unit as part of its artificial intelligence push. The bank aims to leverage AI technologies to develop new products, drive customer engagement, improve productivity, and prioritize risk management.

Portfolio Pulse from Anusuya Lahiri

June 22, 2023 | 12:46 pm

MBOT

Microbot Medical Inc. (NASDAQ:MBOT) has received a Grant of Protection from the Japan Patent Office for a Design Patent covering the robotic drive of the LIBERTY Robotic Surgical System. This expands the company's global IP portfolio, which includes 19 issued/allowed patents and 41 pending applications.

Portfolio Pulse from Happy Mohamed

June 22, 2023 | 12:43 pm

GILD

Kite Pharma, a Gilead Company, has announced the completion of the Marketing Authorization transfer for Yescarta CAR T-cell therapy in Japan from Daiichi Sankyo to Gilead Sciences K.K. The Kite Cell Therapy Business Unit of Gilead Sciences K.K. will now manage the sales and promotion activities of Yescarta in Japan.

Portfolio Pulse from Happy Mohamed

June 22, 2023 | 12:38 pm

KYMR

Kymera Therapeutics has received FDA Orphan Drug Designation for its MDM2 degrader, KT-253, for the treatment of acute myeloid leukemia.

Portfolio Pulse from Bill Haddad

June 22, 2023 | 12:35 pm

ROP

Roper Technologies has announced its decision to transfer its stock exchange listing from the New York Stock Exchange (NYSE) to Nasdaq.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 12:32 pm

CENN

Cenntro Electric Group has received an extension from Nasdaq to regain compliance with the minimum bid price rule. The company now has until August 9, 2022, to meet the requirement.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 12:31 pm

AYRO

Electric vehicle manufacturer AYRO has submitted its new electric vehicle, Vanish, for testing.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 12:18 pm